News

3 Coronavirus Stocks With Long-Term Growth Potential

Abbott Laboratories (NYSE: ABT), Moderna (NASDAQ: MRNA), and Novavax (NASDAQ: NVAX) have each grown amid the new coronavirus market in different ways. Abbott's coronavirus testing business could

TheMotleyFool

0

How Risky Is Aurora Cannabis Stock?

Aurora Cannabis (NYSE: ACB) is easy to see as a particularly risky cannabis company, especially since its stock price effectively collapsed this year, dropping nearly 80% since Jan. 1. Between the

TheMotleyFool

0

IRA Vs. 401(k): These 4 Questions Will Help You Choose

Saving for retirement is important, no matter what type of plan you opt to house your money in. But IRAs and 401(k)s differ in many ways, and choosing the right account could be instrumental in

TheMotleyFool

0

Better Coronavirus Stock: Quidel or Guardant Health?

Throughout the turmoil of the pandemic, Quidel Corporation (NASDAQ: QDEL) and Guardant Health (NASDAQ: GH) are continuing to innovate with their medical testing and diagnostic products. Both

TheMotleyFool

0

5 Hot Stocks to Buy in November

If there's one takeaway from 2020, it's that making careful investment choices is as important as ever. This month, the stock market has continued to react to sharp domestic and global spikes in new

TheMotleyFool

0

A State-by-State Look at Where Marijuana Is Legal

Over the next decade, marijuana could well be one of the fastest-growing industries in the United States. Tech stocks may be the toast of Wall Street this year, but "Marijuana Business Factbook

TheMotleyFool

0

3 Ways Medicare Open Enrollment Could Save You Money

Two of the federal government's biggest programs help older Americans make ends meet in retirement. Social Security offers monthly income, but for many people, Medicare's healthcare coverage is

TheMotleyFool

0

Better Coronavirus Stock: AstraZeneca vs. Pfizer

Comparing AstraZeneca (NASDAQ: AZN) and Pfizer (NYSE: PFE) would have been a much different exercise just one year ago. However, things have changed significantly for both drugmakers in 2020 because

TheMotleyFool

0

Better Coronavirus Stock: Gilead Sciences or Abbott Laboratories?

The coronavirus pandemic in the U.S. is now in its third wave. For stock investors, it's important to have at least one stock in your portfolio that can perform well amid the pandemic. Whether

TheMotleyFool

0

3 Top Growth Stocks to Buy Right Now

October wasn't a great month in the stock market, with investors' growing concerns surrounding the coronavirus pandemic leading to a late-month sell-off. Many sectors felt the impact, and many

TheMotleyFool

0

10 States Disbursing Huge Social Security Checks

It's no secret: Social Security is a foundational program for our nation's retired workers. Each month, the program pays out benefits to nearly 65 million people, 46.1 million of whom are retirees

TheMotleyFool

0

3 Post-Election Stocks Robinhood Investors Should Buy

Investing in 2020 has been challenging, to say the least. Even with volatility always present in the stock market, the wild vacillations we've witnessed in equities this year on the heels of the

TheMotleyFool

0

Better Marijuana Stock: Cresco Labs vs. Village Farms International

Cannabis companies Cresco Labs (OTC: CRLBF) and Village Farms International (NASDAQ: VFF) have both been around for awhile, and both have seen strong recent revenue growth thanks to acquisitions.

TheMotleyFool

0

Why Is No One Talking About DexCom Stock?

Glucose monitor maker DexCom (NASDAQ: DXCM) has had a rough month. After a Wall Street analyst downgraded the stock Oct. 2 and sharply trimmed its price target, the price fell over the next 30 days

TheMotleyFool

0